Quick Order Cart

Cat. No. ARG39331

DNAJC6 Knockout NCI-H1975 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Lung

  • Disease:

    Carcinoma

DNAJC6 Knockout NCI-H1975 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell pool derived from the EGFR L858R mutant NCI-H1975 lung adenocarcinoma line. Disruption of DNAJC6, encoding the clathrin uncoating co?chaperone auxilin, impairs clathrin-mediated endocytosis by preventing Hsc70-dependent disassembly of clathrin coats. This model enables investigation of EGFR internalization and signaling in NSCLC, as well as endocytosis-dependent processes. Applications include transferrin uptake assays, EGF internalization studies, and examination of trafficking defects relevant to Parkinson??s disease, making it a versatile tool for cancer and neurodegeneration research.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    NCI-H1975

    Sex of Donor

    Female

    Gene Name

    DNAJC6

    Gene Identifier

    NCBI Gene ID 9829

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

DNAJC6 Knockout NCI-H1975 Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population derived from the NCI-H1975 human lung adenocarcinoma cell line. This polyclonal pool carries targeted disruption of the DNAJC6 gene, which encodes the J-domain protein auxilin, a critical co?chaperone in clathrin-mediated endocytosis. The cell population is generated by CRISPR/Cas9-mediated gene disruption, providing a heterogeneous knockout model suitable for studying loss-of-function phenotypes without clonal selection artifacts.

The NCI-H1975 cell line is a widely used model of non-small cell lung cancer (NSCLC) adenocarcinoma, established from a patient with an activating EGFR L858R mutation. This mutation drives constitutive signaling through MAPK/ERK and PI3K/AKT pathways, making cells highly dependent on EGFR for proliferation and survival. The line exhibits epithelial morphology and retains lung adenocarcinoma characteristics, providing a valuable substrate for investigating oncogenic signaling and endocytic trafficking of receptor tyrosine kinases.

DNAJC6 (auxilin) functions as a J-domain co?chaperone that recruits Hsc70/HSPA8 to clathrin?coated pits, where it interacts with clathrin heavy chain and the AP?2 complex to stimulate ATP?dependent uncoating of clathrin lattices. In the endocytic pathway, DNAJC6 operates downstream of AP?2 cargo selection and upstream of dynamin?mediated scission. Knockout impairs clathrin disassembly, disrupting the endocytic cycle and potentially affecting internalization of cargo receptors such as EGFR. Key components??clathrin, AP?2, dynamin, Hsc70, and endosomal sorting complexes??converge on vesicle budding and recycling processes sensitive to auxilin levels.

In the EGFR L858R mutant NCI-H1975 background, DNAJC6 knockout is expected to perturb clathrin-dependent endocytosis of EGFR itself, thereby altering receptor internalization kinetics and downstream signal attenuation. Because clathrin-mediated endocytosis plays a key role in regulating the duration and strength of oncogenic EGFR signaling, loss of auxilin may lead to sustained surface receptor levels and enhanced proliferative signaling, or, conversely, interfere with signaling compartmentalization. This polyclonal knockout model enables dissection of the interplay between the endocytic machinery and mutant EGFR-driven tumor cell biology, providing a unique tool for examining how trafficking defects contribute to cancer cell phenotypes.

Researchers can employ this knockout cell pool to investigate clathrin-mediated endocytosis using transferrin uptake, EGF internalization, immunofluorescence of clathrin-coated pits, and flow cytometry for surface receptors. The model suits probing DNAJC6??s role in EGFR trafficking and endocytosis-dependent drug delivery. Given the link of DNAJC6 mutations to juvenile-onset Parkinson??s disease, these cells serve as a paradigm for neurodegeneration-relevant endocytic defects. Applications include Western blotting for clathrin and EGFR, electron microscopy of endocytic structures, and siRNA rescue experiments. For further information, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)